Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 134.98

-4.0%

3:12 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (1133)	6/6/2003 10:00:05 PM
From: quidditch	of 1834

Maybe a munch NIBX was considering just got $200 m more expensive amid the recent BT mania, or maybe the gnrh results in the clinic or preclinical are generating a wider range of indications about which management is excited. Insurance policy against indiplon failure--or competition? Doesn't seem right after PFE's huge vote of confidence. quid

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next